SEC Filings
North Reef Reports 5.04% Passive Stake In Ameris Bancorp
The investment adviser reported shared voting and sale authority over 3,380,000 common shares held at September's end.
SEC Filings
The investment adviser reported shared voting and sale authority over 3,380,000 common shares held at September's end.
SEC Filings
The investment firm reported shared voting and sale authority over 10,259,844 shares held for private investment partnerships.
SEC Filings
The investment manager reported shared voting and sale powers and certified that the holdings have no control-changing purpose.
SEC Filings
Clients keep the dividends and sale proceeds, while the investment manager reported shared voting and disposal powers.
SEC Filings
ARK Genomic Revolution ETF was the only client with an interest above 5% in the reported shares.
SEC Filings
ARK Innovation ETF was the client identified as holding an interest above 5% in the reported shares.
SEC Filings
The September 30 position covers 20,508,004 shares and was jointly reported by ARK and its chief executive.
SEC Filings
The insurer set December 23, 2026, as the record date for its next cash payout.
SEC Filings
The investment manager and Catherine D. Wood reported the same shares, with different voting and disposal powers.
SEC Filings
The investment manager's report covered 1,913,123 common shares held as of September 30.
SEC Filings
Catherine D. Wood reported shared voting authority over the same position in the cancer-testing company.
SEC Filings
The investment manager's September 30 position covered 44,745,024 shares in the AI drug developer.